Annual SG&A:
$300.91M-$31.63M(-9.51%)Summary
- As of today, PTCT annual SG&A is $300.91 million, with the most recent change of -$31.63 million (-9.51%) on December 31, 2024.
- During the last 3 years, PTCT annual SG&A has risen by +$15.14 million (+5.30%).
- PTCT annual SG&A is now -9.51% below its all-time high of $332.54 million, reached on December 31, 2023.
Performance
PTCT SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly SG&A:
$84.05M-$1.22M(-1.43%)Summary
- As of today, PTCT quarterly SG&A is $84.05 million, with the most recent change of -$1.22 million (-1.43%) on September 30, 2025.
- Over the past year, PTCT quarterly SG&A has increased by +$10.59 million (+14.42%).
- PTCT quarterly SG&A is now -9.35% below its all-time high of $92.72 million, reached on December 31, 2022.
Performance
PTCT Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SG&A:
-$12.10B+$751.72M(+5.85%)Summary
- As of today, PTCT TTM SG&A is -$12.10 billion, with the most recent change of +$751.72 million (+5.85%) on September 30, 2025.
- Over the past year, PTCT TTM SG&A has dropped by -$12.39 billion (-4237.03%).
- PTCT TTM SG&A is now -4265.27% below its all-time high of -$277.22 million.
Performance
PTCT TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, General & Administrative Expenses Formula
SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development
PTCT Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -9.5% | +14.4% | -4237.0% |
| 3Y3 Years | +5.3% | +4.9% | -3883.8% |
| 5Y5 Years | +48.6% | +45.3% | -5289.3% |
PTCT Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -9.5% | +5.3% | -9.3% | +20.9% | -31.8% | +14.0% |
| 5Y | 5-Year | -9.5% | +48.6% | -9.3% | +45.3% | -118.7% | +14.0% |
| All-Time | All-Time | -9.5% | +1958.9% | -9.3% | +1791.8% | -4265.3% | +14.0% |
PTCT Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $84.05M(-1.4%) | $334.95M(+3.3%) |
| Jun 2025 | - | $85.26M(+5.3%) | $324.36M(+5.1%) |
| Mar 2025 | - | $80.96M(-4.4%) | $308.60M(+2.6%) |
| Dec 2024 | $300.91M(-9.5%) | $84.68M(+15.3%) | $300.91M(+2.9%) |
| Sep 2024 | - | $73.46M(+5.7%) | $292.52M(-2.5%) |
| Jun 2024 | - | $69.50M(-5.1%) | $299.95M(-5.9%) |
| Mar 2024 | - | $73.27M(-4.0%) | $318.90M(-4.1%) |
| Dec 2023 | $332.54M(+2.0%) | $76.29M(-5.7%) | $332.54M(-4.7%) |
| Sep 2023 | - | $80.89M(-8.6%) | $348.97M(+0.2%) |
| Jun 2023 | - | $88.45M(+1.8%) | $348.20M(+2.5%) |
| Mar 2023 | - | $86.91M(-6.3%) | $339.64M(+4.2%) |
| Dec 2022 | $326.00M(+14.1%) | $92.72M(+15.7%) | $326.00M(+1.9%) |
| Sep 2022 | - | $80.12M(+0.3%) | $319.83M(+3.5%) |
| Jun 2022 | - | $79.89M(+9.0%) | $308.96M(+3.7%) |
| Mar 2022 | - | $73.27M(-15.3%) | $297.95M(+4.3%) |
| Dec 2021 | $285.77M(+16.6%) | $86.55M(+25.0%) | $285.77M(+4.0%) |
| Sep 2021 | - | $69.25M(+0.5%) | $274.68M(+4.3%) |
| Jun 2021 | - | $68.88M(+12.7%) | $263.27M(+6.1%) |
| Mar 2021 | - | $61.09M(-19.0%) | $248.05M(+1.2%) |
| Dec 2020 | $245.16M(+21.0%) | $75.46M(+30.5%) | $245.16M(+5.1%) |
| Sep 2020 | - | $57.84M(+7.8%) | $233.21M(+3.8%) |
| Jun 2020 | - | $53.66M(-7.8%) | $224.65M(+2.0%) |
| Mar 2020 | - | $58.21M(-8.3%) | $220.21M(+8.7%) |
| Dec 2019 | $202.54M(+31.9%) | $63.50M(+28.8%) | $202.54M(+7.9%) |
| Sep 2019 | - | $49.28M(+0.1%) | $187.71M(+6.2%) |
| Jun 2019 | - | $49.22M(+21.4%) | $176.79M(+9.7%) |
| Mar 2019 | - | $40.54M(-16.7%) | $161.12M(+4.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | $153.55M(+26.6%) | $48.67M(+26.8%) | $153.55M(+9.4%) |
| Sep 2018 | - | $38.37M(+14.4%) | $140.36M(+5.2%) |
| Jun 2018 | - | $33.55M(+1.7%) | $133.42M(+3.6%) |
| Mar 2018 | - | $32.97M(-7.1%) | $128.74M(+6.2%) |
| Dec 2017 | $121.27M(+24.9%) | $35.48M(+12.9%) | $121.27M(+10.3%) |
| Sep 2017 | - | $31.42M(+8.9%) | $109.96M(+7.6%) |
| Jun 2017 | - | $28.87M(+13.2%) | $102.19M(+5.7%) |
| Mar 2017 | - | $25.50M(+5.5%) | $96.69M(-0.5%) |
| Dec 2016 | $97.13M(+18.3%) | $24.17M(+2.2%) | $97.13M(-1.7%) |
| Sep 2016 | - | $23.65M(+1.2%) | $98.84M(+2.4%) |
| Jun 2016 | - | $23.37M(-9.9%) | $96.56M(+6.8%) |
| Mar 2016 | - | $25.94M(+0.2%) | $90.40M(+10.1%) |
| Dec 2015 | $82.08M(+83.1%) | $25.89M(+21.1%) | $82.08M(+10.6%) |
| Sep 2015 | - | $21.37M(+24.2%) | $74.21M(+17.1%) |
| Jun 2015 | - | $17.21M(-2.3%) | $63.37M(+15.4%) |
| Mar 2015 | - | $17.61M(-2.2%) | $54.90M(+22.5%) |
| Dec 2014 | $44.82M(+77.7%) | $18.02M(+71.1%) | $44.82M(+30.7%) |
| Sep 2014 | - | $10.53M(+20.6%) | $34.29M(+12.7%) |
| Jun 2014 | - | $8.73M(+15.8%) | $30.44M(+7.6%) |
| Mar 2014 | - | $7.54M(+0.8%) | $28.30M(+12.2%) |
| Dec 2013 | $25.22M(+72.6%) | $7.48M(+12.0%) | $25.22M(+42.2%) |
| Sep 2013 | - | $6.68M(+1.3%) | $17.74M(+60.4%) |
| Jun 2013 | - | $6.60M(+47.8%) | $11.06M(+147.8%) |
| Mar 2013 | - | $4.46M(+0.4%) | $4.46M(+0.4%) |
| Dec 2012 | $14.62M(-9.5%) | - | - |
| Mar 2012 | - | $4.44M | $4.44M |
| Dec 2011 | $16.15M | - | - |
FAQ
- What is PTC Therapeutics, Inc. annual SG&A?
- What is the all-time high annual SG&A for PTC Therapeutics, Inc.?
- What is PTC Therapeutics, Inc. annual SG&A year-on-year change?
- What is PTC Therapeutics, Inc. quarterly SG&A?
- What is the all-time high quarterly SG&A for PTC Therapeutics, Inc.?
- What is PTC Therapeutics, Inc. quarterly SG&A year-on-year change?
- What is PTC Therapeutics, Inc. TTM SG&A?
- What is the all-time high TTM SG&A for PTC Therapeutics, Inc.?
- What is PTC Therapeutics, Inc. TTM SG&A year-on-year change?
What is PTC Therapeutics, Inc. annual SG&A?
The current annual SG&A of PTCT is $300.91M
What is the all-time high annual SG&A for PTC Therapeutics, Inc.?
PTC Therapeutics, Inc. all-time high annual SG&A is $332.54M
What is PTC Therapeutics, Inc. annual SG&A year-on-year change?
Over the past year, PTCT annual SG&A has changed by -$31.63M (-9.51%)
What is PTC Therapeutics, Inc. quarterly SG&A?
The current quarterly SG&A of PTCT is $84.05M
What is the all-time high quarterly SG&A for PTC Therapeutics, Inc.?
PTC Therapeutics, Inc. all-time high quarterly SG&A is $92.72M
What is PTC Therapeutics, Inc. quarterly SG&A year-on-year change?
Over the past year, PTCT quarterly SG&A has changed by +$10.59M (+14.42%)
What is PTC Therapeutics, Inc. TTM SG&A?
The current TTM SG&A of PTCT is -$12.10B
What is the all-time high TTM SG&A for PTC Therapeutics, Inc.?
PTC Therapeutics, Inc. all-time high TTM SG&A is -$277.22M
What is PTC Therapeutics, Inc. TTM SG&A year-on-year change?
Over the past year, PTCT TTM SG&A has changed by -$12.39B (-4237.03%)